Filing Details

Accession Number:
0001179110-13-017667
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-10 16:15:28
Reporting Period:
2013-12-06
Filing Date:
2013-12-10
Accepted Time:
2013-12-10 16:15:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
744218 Celldex Therapeutics Inc. CLDX In Vitro & In Vivo Diagnostic Substances (2835) 133191702
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1255348 W Avery Catlin C/o Celldex Therapeutics, Inc.
119 Fourth Avenue
Needham MA 02494
Sr. Vp & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-12-06 183,333 $8.16 197,442 No 4 M Direct
Common Stock Disposition 2013-12-06 183,333 $24.50 14,109 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option Disposition 2013-12-06 49,016 $0.00 49,016 $8.16
Common Stock Non-Qualified Stock Option Disposition 2013-12-06 134,317 $0.00 134,317 $8.16
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
134,317 2009-03-07 2015-03-07 No 4 M Direct
0 2009-03-07 2015-03-07 No 4 M Direct
Footnotes
  1. The option vested in four equal annual installments on March 7, 2009, March 7, 2010, March 7, 2011 and March 7,2012.
  2. The option vested in four annual installments. 33,580 shares on March 7, 2009 and 33,579 shares on March 7, 2010, March 7, 2011 and March 7, 2012.